We are a global biopharmaceutical company driven by the belief that everyone, everywhere deserves access to affordable, quality medicines. At Biocon, we pioneer novel approaches to improve patient outcomes today, for a better tomorrow. We constantly find new ways to treat diabetes, cancer and autoimmune diseases to improve the quality of life for an ageing population.
CONTACT
Group Companies
FACT SHEET
Biocon At A Glance
Making affordable healthcare
accessible to all
FACTSHEET
Advancing biotechnology for 45+ years
Improving lives across 120+ countries
Talented, dedicated workforce of 16,500+ employees
OUR BUSINESSES
OUR BUSINESSES
Generics
Biosimilars
Research Services
Novel Biologics
A CULTURE OF INNOVATION
A CULTURE OF INNOVATION
0
Patents Granted (Small Molecules)
Till end of FY25
0
Patents Granted (Biologics)
Till end of FY25
0
+
cGMP Approvals across Generics, Biosimilars
0
Biologics were taken from 'Lab to Patient': 2 Novels and 10 Biosimilars
MANUFACTURING
SUBSIDIARIES
One of India’s largest bio-manufacturing facilities for insulins, monoclonal antibodies and devices
The largest integrated insulin manufacturing and R&D facility in Malaysia
Biocon Biologics delivers high-quality, cost-effective biosimilars and operates state-of-the-art manufacturing facilities in India and Malaysia to address healthcare needs worldwide. It has the largest facility in India dedicated to manufacturing monoclonal antibodies (mAbs), and its Johor, Malaysia, plant is Asia’s largest integrated insulin manufacturing site.
Syngene is a contract research, development and manufacturing organization that provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods and agrochemical companies.
OUR REVENUES
GLOBAL EMPLOYEE BASE
Know more
about us
FINANCIAL CALENDAR
BIOCON FOUNDATION
MEET OUR EMPLOYEES
OUR CULTURE
